Key result
Targeted antihypertensive therapies improve survival and reduce cardiovascular events in high-risk patients.
Why the study?
Management of hypertension in the high cardiovascular risk population remains challenging due to aging, increasing diabetes incidence, and more survivors of acute myocardial infarction.
This review summarizes the evidence and guidelines for managing hypertension in high-risk patients with CHD, HF, and diabetes, emphasizing individualized pharmacologic therapy to achieve a target BP of <130/80 mmHg.
May support targeted antihypertensives in high-risk CHD, HF, and diabetes patients; leaves open optimal strategies amid aging and rising comorbidities.
The incidence of hypertension is increasing every year. Blood pressure (BP) control is an important therapeutic goal for the slowing of progression as well as for the prevention of Cardiovascular disease. The management of hypertension in the high cardiovascular risk population remains a real challenge as the population continues to age, the incidence of diabetes increases, and more and more people survive acute myocardial infarction. We will review hypertension management in the high cardiovascular risk population: patients with coronary heart disease (CHD) and heart failure (HF) as well as in diabetic patients.
No takes yet. Share an insight, caveat, or question.
Maraj et al. (2013) conducted a review in Hypertension in high cardiovascular risk populations. Antihypertensive therapy was evaluated. Targeted antihypertensive therapies, including beta-blockers, ACE inhibitors, ARBs, and diuretics, improve mortality and reduce cardiovascular events in patients with CHD, heart failure, and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: